CBFB and leukemia: Given that deletion of the HABD domain from CBFβ-SMMHC reduces its binding affinity for RUNX1 (24), these findings suggest that the attenuated interaction between RUNX1 and CBFβ-SMMHC leads to delayed leukemia development but does not impact the overall leukemogenic potential of the fusion protein.